Keywords: DES، استنت های تخفیف دارویی; bioresorbable scaffold; stent thrombosisACS, acute coronary syndromes; BVS, bioresorbable vascular scaffolds; DES, drug-eluting stents; LVEF, left ventricular ejection fraction; MLD, minimum lumen diameter; QCA, quantitative coronary angiography; RVD, ref
مقالات ISI DES، استنت های تخفیف دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DES، استنت های تخفیف دارویی; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CI, confidence interval; DES, drug-eluting stents; HR, hazard ratio; ICD, International Classification of Diseases; PCI, percutaneous coronary intervention; PCI-S, PCI with stenting23.1;
Keywords: DES، استنت های تخفیف دارویی; ARC, Academic Research Consortium; BRS, bioresorbable scaffold; DES, drug-eluting stents; LAD, left anterior descending coronary artery; MACE, major adverse cardiac event; OCT, optical coherence tomography; PCI, percutaneous coronary intervention; TLR, ta
Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions : 3-Year Results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) Trial
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stent(s); DES, drug-eluting stents; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stent(s); TLR, target lesion revascularization
A Randomized Study to Compare Bioactive Titanium Stents and Everolimus-eluting Stents in Diabetic Patients (TITANIC XV): 1-year Results
Keywords: DES، استنت های تخفیف دارویی; DES, drug-eluting stents; LLL, late lumen loss; PCI, percutaneous coronary intervention; TiNOX, titanium-nitride-oxide; TLR, target lesion revascularization; TVR, target vessel revascularizationEverolimus-eluting stent; Titanium stent; Diabetes mellitus;
Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions : Nordic Bifurcation Study 5-Year Follow-Up Results
Keywords: DES، استنت های تخفیف دارویی; bifurcation; drug-eluting stent; randomized; restenosis; stent thrombosisCABG, coronary artery bypass graft operation; DES, drug-eluting stents; MACE, major adverse cardiac events; MI, myocardial infarction; MV, main vessel; PCI, percutaneous coronary int
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: A procedural performance comparison with sirolimus- and everolimus-eluting stents
Keywords: DES، استنت های تخفیف دارویی; DES, drug-eluting stents; EES, everolimus-eluting stent; MACE, Major adverse coronary events; MI, Myocardial infarction; MV, main vessel; PCI, percutaneous coronary interventions; SB, side-branch; SES, sirolimus-eluting stent; TVR, Target vessel revascula
Polymer-free Sirolimus-eluting Versus Polymer-based Paclitaxel-eluting Stents: An Individual Patient Data Analysis of Randomized Trials
Keywords: DES، استنت های تخفیف دارویی; DES, drug-eluting stents; LLL, late lumen loss; MI, myocardial infarction; PB-PES, polymer-based paclitaxel-eluting stents; PF-SES, polymer-free sirolimus-eluting stents; ST, stent thrombosisLate lumen loss; Paclitaxel-eluting stent; Polymer; Sirolimus-el
Update on Interventional Cardiology
Keywords: DES، استنت های تخفیف دارویی; DES, drug-eluting stents; EES, everolimus-eluting stents; FFR, fractional flow reserve; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stentsPercutaneous coronary intervention; Stents; Drug-eluting stents; Percutaneous noncoronary interve
Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study ★
Keywords: DES، استنت های تخفیف دارویی; CABG, coronary artery bypass surgery; CAD, coronary artery disease; CCS, Canadian Cardiovascular Class; DES, drug-eluting stents; HbA1c, glycosylated hemoglobin A1c; IVUS, intravascular ultrasound; MI, myocardial infarction; PCI, percutaneous coronary int
The Incidence and Timing of Noncardiac Surgery after Cardiac Stent Implantation
Keywords: DES، استنت های تخفیف دارویی; ACC/AHA, American College of Cardiology/American Heart Assoication; BMS, bare metal stents; CMS, Centers for Medicare and Medicaid Services; CPT, Current Procedure Terminology; DES, drug-eluting stents; FY, fiscal year; RVU, relative value units; VA, Vete
Contemporary outcomes of percutaneous intervention in chronic total coronary occlusions due to in-stent restenosis
Keywords: DES، استنت های تخفیف دارویی; PCI, Percutaneous Coronary Intervention; CTO, Chronic Total Occlusion; ISR, In-Stent Restenosis; TIMI, Thrombolysis in Myocardial Infarction; DES, Drug-Eluting Stents; BMS, Bare Metal Stents; RCA, Right Coronary Artery; LAD, Left Anterior Descending; OTW,
Optimal Outcomes for Patients with Blunt Cerebrovascular Injury (BCVI): Tailoring Treatment to the Lesion
Keywords: DES، استنت های تخفیف دارویی; BCVI, blunt cerebrovascular injuries; BMS, bare metal stents; CAI, carotid artery injuries; CT, computerized tomography; DES, drug-eluting stents; PTT, partial thromboplastin time; VAI, vertebral artery injuries
Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography
Keywords: DES، استنت های تخفیف دارویی; bioresorbable scaffolds; incomplete stent; late acquired incomplete stent; optical coherence tomography; strut apposition; uncovered strutsBVS, bioresorbable vascular scaffolds; DES, drug-eluting stents; ISA, incomplete scaffold/strut apposition; IVUS, in
Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration
Keywords: DES، استنت های تخفیف دارویی; VSMC, vascular smooth muscle cell; CAD, coronary artery disease; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; DES, drug-eluting stents; SMGS, smooth muscle cell growth supplement; BrdU, 5-bromo-2-deoxyuridine; MTT, 3-[4,
A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus- Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries : The ZoMaxx I Trial
Keywords: DES، استنت های تخفیف دارویی; drug-eluting stent; stent; zotarolimus; restenosis; coronary artery diseaseCK, creatine kinase; DES, drug-eluting stents; IVUS, intravascular ultrasound; MACE, major adverse cardiovascular events; MLD, minimum lumen diameter; PC, phosphorylcholine; TLR, t
Long-Term Outcomes After Management of Restenosis or Thrombosis of Drug-Eluting Stents
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stent(ing); DES, drug-eluting stents; ISR, in-stent restenosis; MACE, major adverse cardiovascular events; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; STH, stent th
Coronary Collateral Function Long After Drug-Eluting Stent Implantation
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stents; CAD, coronary artery disease; CFI, collateral flow index; CVP, central venous pressure; DES, drug-eluting stents; ECG, electrocardiographic; FFR, fractional flow reserve; PCI, percutaneous coronary intervention
Trends in Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions: A 25-Year Experience From the Mayo Clinic
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stents; CABG, coronary artery bypass grafting; CTO, chronic total occlusion; DES, drug-eluting stents; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; TLR, target lesion revasculariza
Are Drug-Eluting Stents the Preferred Treatment for Multivessel Coronary Artery Disease?
Keywords: DES، استنت های تخفیف دارویی; ARTS, Arterial Revascularization Therapies Study; BMS, bare-metal stent; CABG, coronary artery bypass grafting; CAD, coronary artery disease; DES, drug-eluting stents; ERACI, Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty ver
New Opportunities for Identification and Reduction of Coronary Risk : Treatment of Vulnerable Patients, Arteries, and Plaques
Keywords: DES، استنت های تخفیف دارویی; CT, computed tomography; DES, drug-eluting stents; IVUS, intravascular ultrasound; MI, myocardial infarction; MR, magnetic resonance; MSCT, multislice computed tomography; PCI, percutaneous coronary intervention; PROVE IT–TIMI 22, Pravastatin or Atorvasta
Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stents; DES, drug-eluting stents; IQR, interquartile range; ISR, in-stent restenosis; MACE, major adverse cardiac events; PES, paclitaxel-eluting stents; SES, sirolimus-eluting stents; TLR, target lesion revascularization; TVR, target vess
Characterization of Plaque Prolapse After Drug-Eluting Stent Implantation in Diabetic Patients: A Three-Dimensional Volumetric Intravascular Ultrasound Outcome Study
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stents; CSA, cross-sectional area; DES, drug-eluting stents; DIABETES, Diabetes and Sirolimus-Eluting Stent trial; DS, diameter stenosis; EEM, external elastic membrane; IVUS, intravascular ultrasound; MLD, minimal lumen diameter; PP, plaq
Clinical Guidelines and Practice: In Search of the Truth
Keywords: DES، استنت های تخفیف دارویی; ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; CPG, clinical practice guideline; DES, drug-eluting stents; ECG, electrocardiogram; GPI, glycoprotein IIb/IIIa inhibitor; MI, myocardial infarction; NSTEAC
Serial Angiographic Follow-Up of Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Revascularization
Keywords: DES، استنت های تخفیف دارویی; CABG, coronary bypass surgery; DES, drug-eluting stents; IVUS, intravascular ultrasound; LAD, left anterior descending coronary artery; LCX, left circumflex artery; LMCA, left main coronary artery; MACE, major adverse cardiac events; MI, myocardial infarc
Two-Year Follow-Up of the Quantitative Angiographic and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric Paclitaxel-Eluting Stent Implantation : Late “Catch-Up” Phenomenon From ASPECT Study
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stents; DES, drug-eluting stents; IH, intimal hyperplasia; IVUS, intravascular ultrasound; MLA, minimum lumen area; MLD, minimal luminal diameter; QCA, quantitative coronary angiography
Pathology of Drug-Eluting Stents in Humans : Delayed Healing and Late Thrombotic Risk
Keywords: DES، استنت های تخفیف دارویی; BMS, bare-metal stents; DES, drug-eluting stents; FDA, Food and Drug Administration; LST, late stent thrombosis
Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents
Keywords: DES، استنت های تخفیف دارویی; DES, drug-eluting stents; IVUS, intravascular ultrasound; LAST, late angiographic stent thrombosis; MI, myocardial infarction; PES, paclitaxel-eluting stents; SES, sirolimus-eluting stents; TIMI, Thrombolysis In Myocardial Infarction